Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Recombinant Human eNOS Protein
CAS number:unknown molecular formula:
overview
compound introduction
Specs
| Chinese alias | 重组人eNOS蛋白 | 重组人eNOS蛋白 | ||
| English alias | Constitutive NOS | EC NOS | EC-NOS | ecNOS | Endothelial nitric oxidase synthase | Endothelial nitric oxide synthase | Endothelial nitric oxide synthase 3 | Endothelial NOS | eNOS | Nitric oxide synthase 3 | Nitric oxide synthase 3 (endothelial cell) | Ni | ||
| CAS number | unknown | molecular formula | |
| molecular weight | - | Exact mass | 无载体 |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS




